Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

MLA

Youngwoo Jeon, et al. “Effectiveness of Pegfilgrastim Prophylaxis in Preventing Febrile Neutropenia during R-FC Chemoimmunotherapy for Chronic Lymphocytic Leukemia: A Multicenter Prospective Phase II Study.” Frontiers in Oncology, vol. 13, Mar. 2023. EBSCOhost, https://doi.org/10.3389/fonc.2023.998014.

APA

Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, & Seok-Goo Cho. (2023). Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.998014

Chicago

Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, et al. 2023. “Effectiveness of Pegfilgrastim Prophylaxis in Preventing Febrile Neutropenia during R-FC Chemoimmunotherapy for Chronic Lymphocytic Leukemia: A Multicenter Prospective Phase II Study.” Frontiers in Oncology 13 (March). doi:10.3389/fonc.2023.998014.